Japan cancels a third of contracted Astrazeneca vaccine purchase of 40 mln doses

Published: Updated:

Japan has cancelled the purchase of about 40 million Astrazeneca Plc COVID-19 vaccine doses it agreed to buy last year, a health ministry official said in parliament on Monday.

The contract allowed the government to cancel a portion of the supply if it was unneeded, the official said in response to lawmakers’ questioning. Japan had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.

Read the latest updates in our dedicated coronavirus section.

About Astrazeneca 200,000 doses have been supplied to local governments in Japan, while 63 million doses have donated overseas, the official added.

For the latest headlines, follow our Google News channel online or via the app.

Japan has predominantly relied on the mRNA-type vaccines developed by Pfizer Inc and Moderna Inc for its COVID inoculations and boosters so far.

Read more:

Taiwan orders 700,000 units of Pfizer’s COVID-19 pill as cases rise

Shanghai COVID-19 cases keep rising, food supply problems persist

China labels US concerns over COVID regulations ‘groundless accusations’

Top Content Trending